ARTHRITOMAB Trademark

Trademark Overview

On Monday, September 11, 2006, a trademark application was filed for ARTHRITOMAB with the United States Patent and Trademark Office. The USPTO has given the ARTHRITOMAB trademark a serial number of 78971140. The federal status of this trademark filing is ABANDONED PETITION TO REVIVE - DENIED as of Tuesday, February 3, 2009. This trademark is owned by MD Biosciences. The ARTHRITOMAB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Product and service for the research and/or screening of compounds for anti-inflammatory properties in arthritis
arthritomab

General Information

Serial Number78971140
Word MarkARTHRITOMAB
Filing DateMonday, September 11, 2006
Status614 - ABANDONED PETITION TO REVIVE - DENIED
Status DateTuesday, February 3, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProduct and service for the research and/or screening of compounds for anti-inflammatory properties in arthritis

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 15, 2006
Primary Code042
First Use Anywhere DateSunday, September 10, 2006
First Use In Commerce DateMonday, September 11, 2006

Trademark Owner History

Party NameMD Biosciences
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt Paul, MN 55114

Trademark Events

Event DateEvent Description
Tuesday, February 3, 2009PETITION TO REVIVE-DENIED
Tuesday, February 3, 2009ASSIGNED TO PETITION STAFF
Friday, January 23, 2009PETITION TO REVIVE-RECEIVED
Friday, January 23, 2009PAPER RECEIVED
Friday, September 5, 2008ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, September 5, 2008ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, February 8, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 8, 2008NON-FINAL ACTION E-MAILED
Friday, February 8, 2008NON-FINAL ACTION WRITTEN
Friday, February 8, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 8, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 7, 2008ASSIGNED TO LIE
Wednesday, January 2, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 6, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 6, 2007NON-FINAL ACTION E-MAILED
Monday, August 6, 2007NON-FINAL ACTION WRITTEN
Monday, July 16, 2007PETITION TO REVIVE-GRANTED
Monday, July 16, 2007TEAS PETITION TO REVIVE RECEIVED
Wednesday, July 11, 2007ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, July 11, 2007ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, December 13, 2006NON-FINAL ACTION E-MAILED
Wednesday, December 13, 2006NON-FINAL ACTION WRITTEN
Wednesday, December 13, 2006ASSIGNED TO EXAMINER
Friday, September 15, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

arthritomab inflammatory properties arthritis anti compounds service research screening product